Efficacy and safety of dasatinib vs. Imatinib in Latin american subpopulation from the dasision trial in patients with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP)
- Publication date
- 16 December 2020
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'